TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27726423

Group type: EXPERIMENTAL
Intervention: Intralesional steroids (8 mg of dexamethasone plus 2 mL of lidocaine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Platelet-Rich Plasma (3 mL of PRP activated with 0.45 mL of 10% calcium gluconate)
Number of subjects: 0
Study: 26375468

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI)
Number of subjects: 1030

Group type: COMPARATOR
Intervention: Control (questionnaire only)
Number of subjects: 1030
Study: 23620431

Group type: EXPERIMENTAL
Intervention: Adaptive optics near infrared (NIR) imaging
Number of subjects: 9

Group type: COMPARATOR
Intervention: Scanning laser ophthalmoscope imaging
Number of subjects: 9
Study: 22070641

Group type: EXPERIMENTAL
Intervention: Interval Exercise (IE: 5 × 2:2 min at 85% and 40% maximal oxygen uptake)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Steady State Exercise (SS: 21 min at 60% maximal oxygen uptake)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control Session
Number of subjects: 13
Study: 19539305

Group type: EXPERIMENTAL
Intervention: Four short sentences
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Eight short sentences
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Four long sentences
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Four random word lists
Number of subjects: 3
Study: 16802542

Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 0
Study: 12588571

Group type: EXPERIMENTAL
Intervention: Home-based quadriceps resistance exercise
Number of subjects: 243

Group type: COMPARATOR
Intervention: Vitamin D (calciferol, 300,000 IU)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Home-based quadriceps resistance exercise and Vitamin D
Number of subjects: 243
Study: 10886041

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Omeprazole 20 mg
Number of subjects: 36
Study: 9372716

Group type: EXPERIMENTAL
Intervention: Diode laser trabeculoplasty
Number of subjects: 11

Group type: COMPARATOR
Intervention: Argon laser trabeculoplasty
Number of subjects: 11
Study: 1535020

Group type: EXPERIMENTAL
Intervention: Leuprorelin acetate depot 3.75 mg injected every 24 days
Number of subjects: 67

Group type: COMPARATOR
Intervention: Danazol 600-800 mg daily
Number of subjects: 67
Study: 3554485

Group type: EXPERIMENTAL
Intervention: Buflomedilhydrochloride (Loftyl)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31743424

Group type: EXPERIMENTAL
Intervention: Optimal individualized treatment regime (ITR) using data from a 2 × 2 crossover study
Number of subjects: 0
Study: 29125051

Group type: EXPERIMENTAL
Intervention: Didactic learning combined with experiential learning (experiential learning group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Didactic learning alone (no experiential learning group)
Number of subjects: 30
Study: 27343714

Group type: EXPERIMENTAL
Intervention: Neurofeedback (NF)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo feedback (PF)
Number of subjects: 82
Study: 24881805

Group type: EXPERIMENTAL
Intervention: Cerebellar continuous theta burst stimulation (cTBS) for two weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cerebellar continuous theta burst stimulation (cTBS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 0
Study: 22278950

Group type: EXPERIMENTAL
Intervention: Tourette syndrome patients
Number of subjects: 11

Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 11
Study: 20609226

Group type: EXPERIMENTAL
Intervention: Sequential medium (group A)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Single medium (group B)
Number of subjects: 147
Study: 18711172

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZA) 4 mg intravenously every 3 months for 1 year
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 14962261

Group type: EXPERIMENTAL
Intervention: Oral treatment with etoposide 80 mg/m² and thioguanine 100 mg/m² twice daily on 5 days and idarubicin 15 mg/m² on 3 days (ETI)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Intravenous combination of cytarabine 100 mg/m² twice daily on 5 days, idarubicin 12 mg/m² x 1, and thioguanine (TAI)
Number of subjects: 92
Study: 11422429

Group type: EXPERIMENTAL
Intervention: NPH insulin (12 U) injected into the carpal tunnel weekly for 7 weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo injected into the carpal tunnel weekly for 7 weeks
Number of subjects: 43
Study: 9422907

Group type: EXPERIMENTAL
Intervention: Local anaesthesia administered before tooth removal
Number of subjects: 78

Group type: COMPARATOR
Intervention: Local anaesthesia administered after tooth removal
Number of subjects: 78
Study: 8387410

Group type: EXPERIMENTAL
Intervention: Standard dose of tetravalent reassortant rhesus rotavirus vaccine (4 x 10(4) PFU)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: High dose of tetravalent reassortant rhesus rotavirus vaccine (4 x 10(5) PFU)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Standard dose of tetravalent reassortant rhesus rotavirus vaccine
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: High dose of tetravalent reassortant rhesus rotavirus vaccine
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Bottle feeding
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Combined serum and salivary responses
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Serum responses alone
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Salivary responses in newborn breastfed infants
Number of subjects: 95
Study: 2441633

Group type: EXPERIMENTAL
Intervention: Ara‐AMP with human leukocyte interferon
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Ara‐AMP with placebo
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Ara‐AMP
Number of subjects: 64
Study: 29933718

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (100 mg per day for 12 weeks)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo (100 mg cellulose acetate per day for 12 weeks)
Number of subjects: 68
Study: 27733521

Group type: EXPERIMENTAL
Intervention: High-amylose maize resistant starch type 2 (HAM-RS2) bagel (25 g/d)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control wheat bagel
Number of subjects: 24
Study: 24113808

Group type: EXPERIMENTAL
Intervention: Directive counsel for typical medical decisions
Number of subjects: 2562

Group type: EXPERIMENTAL
Intervention: Directive counsel for morally controversial medical decisions
Number of subjects: 2562

Group type: EXPERIMENTAL
Intervention: Directive counsel after reading a vignette about palliative sedation
Number of subjects: 2562
Study: 22115804

Group type: EXPERIMENTAL
Intervention: Modified PTBIED (group A)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Conventional PTBIED (group B)
Number of subjects: 43
Study: 20804058

Group type: EXPERIMENTAL
Intervention: Hypotensive anesthesia (induced by speeding up propofol injection and maintaining general anesthesia at 4.4-9 mg/kg x hr)
Number of subjects: 25
Study: 18414111

Group type: EXPERIMENTAL
Intervention: Brinzolamide
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 32

Group type: COMPARATOR
Intervention: Brinzolamide and Timolol
Number of subjects: 32
Study: 16648211

Group type: EXPERIMENTAL
Intervention: Light orthodontic force of 25 cN
Number of subjects: 8

Group type: COMPARATOR
Intervention: Heavy orthodontic force of 225 cN
Number of subjects: 8
Study: 14723093

Group type: EXPERIMENTAL
Intervention: Evra patch, worn for 7 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combined oral contraceptives (COCs), taken daily
Number of subjects: 0
Study: 11010941

Group type: EXPERIMENTAL
Intervention: 50 mg Fe/d as ferrous sulfate for 12 weeks
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 8772471

Group type: EXPERIMENTAL
Intervention: 100 mg hydrocortisone (oral administration)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 25 micrograms of corticotropin-releasing hormone (intravenous administration)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 16
Study: 1478809

Group type: EXPERIMENTAL
Intervention: Drainage with suction (Group B1, 52 patients)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Drainage with gravity (Group B2, 35 patients)
Number of subjects: 173

Group type: COMPARATOR
Intervention: No drainage (Group A, 86 patients)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Drainage (Group B, 87 patients)
Number of subjects: 173
Study: 6229735

Group type: EXPERIMENTAL
Intervention: Flurbiprofen (100 mg/day)
Number of subjects: 383

Group type: COMPARATOR
Intervention: Ergot derivative
Number of subjects: 383
Study: 31631184

Group type: EXPERIMENTAL
Intervention: Training by surgeons
Number of subjects: 46

Group type: COMPARATOR
Intervention: Training by peer monitors
Number of subjects: 46
Study: 29992869

Group type: EXPERIMENTAL
Intervention: Treatment (home visiting program 'Pro Kind')
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Prenatal and current parental stress, enriched family learning environment, children's language competencies
Number of subjects: 39
Study: 27402235

Group type: EXPERIMENTAL
Intervention: Lower dose edoxaban
Number of subjects: 2349

Group type: EXPERIMENTAL
Intervention: Higher dose edoxaban
Number of subjects: 2349

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 2349

Group type: EXPERIMENTAL
Intervention: Digitalis use
Number of subjects: 2349
Study: 25011720

Group type: EXPERIMENTAL
Intervention: TF-TAVR
Number of subjects: 1040

Group type: EXPERIMENTAL
Intervention: TA-TAVR
Number of subjects: 1040

Group type: EXPERIMENTAL
Intervention: AVR
Number of subjects: 1040
Study: 22814850

Group type: EXPERIMENTAL
Intervention: LiRIS 200 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: LiRIS 650 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: LiRIS 200 mg and 650 mg
Number of subjects: 16
Study: 20632059

Group type: EXPERIMENTAL
Intervention: Topical 0.4% glyceryl trinitrate (GTN) treatment for 40 days
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Topical 0.4% glyceryl trinitrate (GTN) treatment for 80 days
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Topical 0.4% glyceryl trinitrate (GTN) treatment (both groups)
Number of subjects: 188
Study: 17846259

Group type: EXPERIMENTAL
Intervention: Supervised exercise
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Home-based exercise
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Antidepressant medication (sertraline, 50-200 mg daily)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo pill
Number of subjects: 202
Study: 15389191

Group type: EXPERIMENTAL
Intervention: Psoriasis Area and Severity Index (PASI)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Psoriasis Global Assessment (PGA)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Lattice System Physician's Global Assessment (LS-PGA)
Number of subjects: 35
Study: 11476360

Group type: EXPERIMENTAL
Intervention: Lispro insulin (LP)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Regular insulin (HR)
Number of subjects: 12
Study: 9836002

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (low dosage)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral estradiol (high pharmacologic dosage)
Number of subjects: 0
Study: 7932128

Group type: EXPERIMENTAL
Intervention: 3.5 mm incision (Group A)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: 4.5 mm incision (Group B)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Both groups (3.5 mm and 4.5 mm)
Number of subjects: 107
Study: 2971504

Group type: EXPERIMENTAL
Intervention: 100 mg dose of depot‐medroxyprogesterone acetate (DMPA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 150 mg dose of depot‐medroxyprogesterone acetate (DMPA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference period method of analysis
Number of subjects: 0
Study: 31954191

Group type: EXPERIMENTAL
Intervention: Timothy grass SLIT-tablet
Number of subjects: 1818

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1818
Study: 29459188

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 55

Group type: COMPARATOR
Intervention: Catheterization
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Sonographic evaluation of bladder volume
Number of subjects: 55
Study: 27246303

Group type: EXPERIMENTAL
Intervention: 12-week physical activity intervention (behavioral counseling, physical activity, home-based walking)
Number of subjects: 40
Study: 24631981

Group type: EXPERIMENTAL
Intervention: Younger drivers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Older drivers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Workload (variability of lead car speed)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control experiment (constant projected size and position of targets)
Number of subjects: 0
Study: 23541417

Group type: EXPERIMENTAL
Intervention: CC and rFSH (group B)
Number of subjects: 259

Group type: COMPARATOR
Intervention: CC and hMG (group A)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 259
Study: 20668943

Group type: EXPERIMENTAL
Intervention: Phenylalanine (Phe) loading test (100 mg/kg)
Number of subjects: 24
Study: 18840367

Group type: EXPERIMENTAL
Intervention: Amlodipine/Ramipril combination therapy (mean dose 7.60/7.60 mg)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Amlodipine monotherapy (mean dose 7.97 mg)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Amlodipine/Ramipril combination therapy
Number of subjects: 222

Group type: COMPARATOR
Intervention: Amlodipine monotherapy
Number of subjects: 222
Study: 16880243

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (4 mg) administered via a 15-minute infusion every 3 or 4 weeks for 12 infusions
Number of subjects: 312

Group type: COMPARATOR
Intervention: Placebo (implied control from randomized phase III trials)
Number of subjects: 312
Study: 12818279

Group type: EXPERIMENTAL
Intervention: 9 mg NT‐3 three times per week (TTW)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 15612515

Group type: EXPERIMENTAL
Intervention: Glimepiride (up to 4 mg)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Metformin (2 g)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Combined therapy (4 mg glimepiride plus 2 g metformin)
Number of subjects: 104
Study: 9971866

Group type: EXPERIMENTAL
Intervention: Thyroxine plus triiodothyronine (12.5 microg of triiodothyronine replacing 50 microg of thyroxine)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Thyroxine alone (usual dose)
Number of subjects: 33
Study: 7750591

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (10 mg/d)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 2180642

Group type: EXPERIMENTAL
Intervention: Resection of the cremaster muscle
Number of subjects: 390

Group type: COMPARATOR
Intervention: No resection of the cremaster muscle
Number of subjects: 390
Study: 7009858

Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sulindac
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salicylates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31924539

Group type: EXPERIMENTAL
Intervention: Zvandiri intervention group (peer-led differentiated service delivery model)
Number of subjects: 496

Group type: COMPARATOR
Intervention: Control group (standard HIV care)
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Zvandiri intervention group
Number of subjects: 496

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 496
Study: 28060083

Group type: EXPERIMENTAL
Intervention: Low-intensity lifestyle intervention program (group sessions, individual counseling, telephone follow-ups over 3 months)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Standard care plus attention placebo (control group)
Number of subjects: 183
Study: 25816110

Group type: EXPERIMENTAL
Intervention: Losartan/Hydrochlorothiazide (Los/HCTZ)
Number of subjects: 110

Group type: COMPARATOR
Intervention: High-dose Losartan (High-Los)
Number of subjects: 110
Study: 23511349

Group type: EXPERIMENTAL
Intervention: Polyurethane SEALGUARD Evac® endotracheal tube
Number of subjects: 29

Group type: COMPARATOR
Intervention: Polyvinyl HI-LO Evac® endotracheal tube
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Larger tubes (size 9)
Number of subjects: 29
Study: 21837956

Group type: EXPERIMENTAL
Intervention: Transurethral plasmakinetic enucleation of the prostate (PKEP)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 90
Study: 19652995

Group type: EXPERIMENTAL
Intervention: Local cold-pack application
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sprint-interval training without cold-pack application
Number of subjects: 12
Study: 17454421

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 15517668

Group type: EXPERIMENTAL
Intervention: Extended-release oxybutynin chloride 10 mg (qd)
Number of subjects: 315

Group type: COMPARATOR
Intervention: Tolterodine tartrate 4 mg (2 mg bid)
Number of subjects: 315
Study: 11432109

Group type: COMPARATOR
Intervention: u-FSH (150 IU/d)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: follitropin-alpha (100 IU/d)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: follitropin-beta (100 IU/d)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: r-FSH
Number of subjects: 88

Group type: COMPARATOR
Intervention: u-FSH
Number of subjects: 88
Study: 9018831

Group type: EXPERIMENTAL
Intervention: Intermittent cooling
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Continuous cooling during intermittent exercise
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Ambient air cooling during continuous exercise
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Continuous air-cooling trial
Number of subjects: 5

Group type: COMPARATOR
Intervention: No cooling (control)
Number of subjects: 5
Study: 7942228

Group type: EXPERIMENTAL
Intervention: Vesical lavage cytology (LC)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Mictional cytology (MC)
Number of subjects: 171
Study: 2967624

Group type: EXPERIMENTAL
Intervention: Oxygenated Fluosol DA, 20% emulsion (FDA-20)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control solutions of oxygenated Ringer's lactate and nonoxygenated FDA-20
Number of subjects: 42

Group type: COMPARATOR
Intervention: Nonperfused sequences
Number of subjects: 42
Study: 31684923

Group type: EXPERIMENTAL
Intervention: Antenatal care (ANC) attendance
Number of subjects: 3784

Group type: EXPERIMENTAL
Intervention: Insecticide-treated net (ITN) ownership and use
Number of subjects: 3784

Group type: COMPARATOR
Intervention: ANC attendance
Number of subjects: 3784

Group type: EXPERIMENTAL
Intervention: Malaria infection prevalence
Number of subjects: 3784
Study: 28947458

Group type: EXPERIMENTAL
Intervention: HIIT A (16 min interval training with 4, 2 and 1 min intervals at 80%-90% of peak oxygen uptake)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HIIT B (4x4 min interval training at 80%-90% VO2peak)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MICT (40 min cycling at 50%-60% VO2peak)
Number of subjects: 0
Study: 25865864

Group type: EXPERIMENTAL
Intervention: Individualised falls-prevention education for patients, supported by training and feedback for staff, delivered as a ward-level programme.
Number of subjects: 3606
Study: 23466918

Group type: EXPERIMENTAL
Intervention: 1% aqueous chlorhexidine gluconate (CHG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 10% povidone-iodine (PI)
Number of subjects: 0
Study: 21875911

Group type: EXPERIMENTAL
Intervention: Deep hypothermia with total circulatory arrest
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Continuous low-flow cardiopulmonary bypass
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Postoperative seizures
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging abnormalities in d-transposition of the great arteries group
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Remedial academic or behavioral services
Number of subjects: 139
Study: 20027369

Group type: EXPERIMENTAL
Intervention: Tenoten
Number of subjects: 0
Study: 17964396

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate 1% (Healon)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Chondroitin sulfate 4%-sodium hyaluronate 3% (Viscoat) in combination with sodium hyaluronate 1% (Provisc)
Number of subjects: 54
Study: 15140340

Group type: EXPERIMENTAL
Intervention: Testosterone buccal system (Striant), 30 mg twice daily
Number of subjects: 28

Group type: COMPARATOR
Intervention: Transdermal gel delivery system (T‐gel), AndroGel 5 g containing 1% (50 mg) T, daily for 14 days
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Testosterone buccal system
Number of subjects: 28

Group type: COMPARATOR
Intervention: Transdermal gel delivery system (T‐gel)
Number of subjects: 28
Study: 11943637

Group type: EXPERIMENTAL
Intervention: Red palm oil (RPO) consumption
Number of subjects: 210
Study: 9419168

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy
Number of subjects: 1330
Study: 7649646

Group type: EXPERIMENTAL
Intervention: Low level laser therapy (LLLT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment from an inactive machine
Number of subjects: 0
Study: 2502843

Group type: EXPERIMENTAL
Intervention: Deprenyl (10 mg/day)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 329943

Group type: EXPERIMENTAL
Intervention: Practolol
Number of subjects: 3053

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3053
Study: 30552041

Group type: EXPERIMENTAL
Intervention: Nicotine (7 mg dermal patch)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Atomoxetine (60 mg per os)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 27146248

Group type: EXPERIMENTAL
Intervention: Provision of lipid-based nutrient supplements plus malaria and diarrhoea treatment from age 9 to 18 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Provision of lipid-based nutrient supplements plus malaria and diarrhoea treatment
Number of subjects: 0